Neovacs S.A. (ALNEV) — Long-term Investment Intensity
Neovacs S.A. (ALNEV) has a Long-term Investment Intensity of 4.9% as of June 2019. Long-term investments of €454.67K represent 4.9% of total assets of €9.22 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ALNEV net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Neovacs S.A. Long-term Investment Intensity (2013–2018)
This chart shows how Neovacs S.A.'s Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of June 2019, the intensity stands at 4.9%, reflecting long-term investments of €454.67K against total assets of €9.22 Million EUR. See defensive interval ratio of Neovacs S.A. to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for Neovacs S.A. (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for Neovacs S.A. from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Neovacs S.A. (ALNEV) total assets.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 8.9% | €643.22K | €7.24 Million | ▲ +1.2 pp |
| 2017 | 7.7% | €894.99K | €11.67 Million | ▲ +0.3 pp |
| 2016 | 7.4% | €689.90K | €9.33 Million | ▲ +6.1 pp |
| 2015 | 1.2% | €140.46K | €11.25 Million | ▼ 0.0 pp |
| 2014 | 1.3% | €116.04K | €9.05 Million | ▲ +0.4 pp |
| 2013 | 0.9% | €65.89K | €7.67 Million | — |